Results 51 to 60 of about 72,623 (283)

A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study. [PDF]

open access: yes, 2013
High expression of ERBB2 has been reported in medulloblastoma and ependymoma; EGFR is amplified and over-expressed in brainstem glioma suggesting these proteins as potential therapeutic targets. We conducted a molecular biology (MB) and phase II study to
Blaney, Susan M.   +11 more
core   +1 more source

Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium

open access: yesBMC Cardiovascular Disorders, 2020
Background Hypokalemia is common in patients treated with antihypertensive drugs, but the impact of correcting hypokalemia is insufficiently studied.
M. Krogager   +9 more
semanticscholar   +1 more source

Congestive heart failure in rats is associated with increased expression and targeting of aquaporin-2 water channel in collecting duct [PDF]

open access: yes, 1997
We tested whether severe congestive heart failure (CHF), a condition associated with excess free-water retention, is accompanied by altered regulation of the vasopressin-regulated water channel, aquaporin-2 (AQP2), in the renal collecting duct.
Andersen, D.   +8 more
core   +2 more sources

Assessment of hypokalemia and clinical prognosis in Patients with COVID-19 in Yangzhou, China.

open access: yesPLoS ONE, 2022
BackgroundHypokalemia is a frequent electrolyte imbalance in patients with COVID-19. The aim of this study was to estimate the association between hypokalemia and clinical prognosis in patients with moderate COVID-19.MethodsA single-center, retrospective,
Jiangtao Yin   +11 more
doaj   +1 more source

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second-Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma. [PDF]

open access: yes, 2017
Lessons learnedThe safety profile in the patient groups who received FOLFIRI and simtuzumab did not differ from that in the FOLFIRI and placebo group.The addition of simtuzumab to chemotherapy with FOLFIRI does not improve clinical outcomes in patients ...
Bendell, Johanna   +5 more
core   +1 more source

Risk of Developing Hypokalemia in Patients With Hypertension Treated With Combination Antihypertensive Therapy

open access: yesHYPERTENSION, 2020
Supplemental Digital Content is available in the text. Little is known about the occurrence of hypokalemia due to combination therapy for hypertension.
M. Krogager   +8 more
semanticscholar   +1 more source

Ultrasound of the diaphragm in severe hypokalemia induced diaphragmatic dysfunction

open access: yesLung India, 2017
Severe hypokalemia presents with significant muscle weakness and involvement of respiratory muscles. Bedside ultrasonography of the diaphragm is emerging as a noninvasive bedside tool for diagnosis and followup of diaphragmatic dysfunction due to various
Gentle Sunder Shrestha   +1 more
doaj   +1 more source

Stroke Mimic: A Case of Unilateral Thyrotoxic Hypokalemic Periodic Paralysis [PDF]

open access: yes, 2020
Thyrotoxic hypokalemic periodic paralysis (THPP) is a condition that results in transient skeletal muscle paralysis secondary to intracellular potassium sequestration.
Lajeunesse, Michael, Young, Scott
core  

Sex‐specific activation of SK current by isoproterenol facilitates action potential triangulation and arrhythmogenesis in rabbit ventricles [PDF]

open access: yes, 2018
Sex has a large influence on cardiac electrophysiological properties. Whether sex differences exist in apamin‐sensitive small conductance Ca2+‐activated K+ (SK) current (IKAS) remains unknown.
Chen, Mu   +10 more
core   +1 more source

Case of severe hypertension and nephrotic range proteinuria [PDF]

open access: yes, 2018
No abstract ...
Bursztyn, Michael   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy